The validity of dependence as a health outcome measure in Alzheimer's disease

American Journal of Alzheimer's Disease and other Dementias

Volumn 28, Issue 3, 2013, Pages 245-252

  Spackman, D Eldon ^a   Kadiyala, Srikanth ^b   Neumann, Peter J ^c   Veenstra, David L ^d   Sullivan, Sean D ^d  

^a UNIVERSITY OF YORK   (United Kingdom)

^b RAND CORPORATION   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer's disease; dependence; functional impairment; outcome assessment

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; ASSOCIATION; BEHAVIOR; BEHAVIOR DISORDER; CLINICAL DEMENTIA RATING; COGNITION; CONSTRUCT VALIDITY; DEMENTIA; EDUCATIONAL STATUS; FEMALE; FUNCTIONAL ACTIVITY QUESTIONNAIRE; FUNCTIONAL DISEASE; HUMAN; INDEPENDENCE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NURSING HOME; OUTCOME ASSESSMENT; PHYSICAL CAPACITY; QUESTIONNAIRE; SOCIAL INTERACTION;

EID: 84876727928     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317513481092     Document Type: Article

References (26)

1. McLaughlin T, Feldman H, Fillit H, et al. Dependence as a unifying construct in defining Alzheimer's disease severity. Alzheimers Dement. 2010 ; 6 (6). 482-493
2. Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007 ; 10 (suppl 2). S125 - S137
3. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002 ; 11 (3). 193-205
4. Holtzer R, Wegesin DJ, Albert SM, et al. The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer's disease. Arch Neurol. 2003 ; 60 (8). 1137-1142
5. Sarazin M, Stern Y, Berr C, et al. Neuropsychological predictors of dependency in patients with Alzheimer's disease. Neurology. 2005 ; 64 (6). 1027-1031
6. Kurtz MM, Moberg PJ, Mozley LH, et al. Cognitive impairment and functional status in elderly institutionalized patients with schizophrenia. Int J Geriatr Psychiatry. 2001 ; 16 (6). 631-638
7. Tun SM, Murman DL, Long HL, Colenda CC, von Eye A. Predictive validity of neuropsychiatric subgroups on nursing home placement and survival in patients with Alzheimer's disease. Am J Geriatr Psychiatry. 2007 ; 15 (4). 314-327
8. Zhu CW, Leibman C, McLaughlin T, et al. The effects of patient function and dependence on costs of care in Alzheimer's disease. J Am Geriatr Soc. 2008 ; 56 (8). 1497-1503
9. Brickman AM, Riba A, Bell K, et al. Longitudinal assessment of patient dependence in Alzheimer's disease. Arch Neurol. 2002 ; 59 (8). 1304-1308
10. Samus QM, Rosenblatt A, Onyike C, et al. Correlates of caregiver-rated quality of life in assisted living: the Maryland Assisted Living study. J Gerontol B Psychol Sci Soc Sci. 2006 ; 61 (5). P311 - P314
11. McLaughlin TP, Neumann PJ, Spackman DE, et al
12. National Alzheimer's Coordinating Center. http://www.alz.washington.edu/. Accessed May 20, 2011.
13. NACC Uniform Data Set (UDS) Coding Guidebook for Initial Visit Packet; 2008. https://www.alz.washington.edu/NONMEMBER/UDS/DOCS/VER2/ivpguide.pdf. Accessed May 20, 2011.
14. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12 (3). 189-198
15. Hensel A, Angermeyer MC, Riedel-Heller SG. Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination. J Neurol Neurosurg Psychiatry. 2007 ; 78 (12). 1298-1303
16. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992 ; 40 (9). 922-935
17. Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982 ; 37 (3). 323-329
18. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994 ; 44 (12). 2308-2314
19. Maidment ID, Fox CG, Boustani M, Rodriguez J, Brown RC, Katona CL. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis. Ann Pharmacother. 2008 ; 42 (1). 32-38
20. Rocca P, Marino F, Montemagni C, Perrone D, Bogetto F. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study. Psychiatry Clin Neurosci. 2007 ; 61 (6). 622-629
21. Trinh NH, Hoblyn J, Mohanty S, Yaffe K. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer's disease: a meta-analysis. JAMA. 2003 ; 289 (2). 210-216
22. Brant R. Assessing proportionality in the proportional odds model for ordinal logistic regression. Biometrics. 1990 ; 46 (4). 1171-1178
23. McLaughlin T, Buxton M, Mittendorf T, et al. Assessment of potential measures in models of progression in Alzheimer's disease. Neurology. 2010 ; 75 (14). 1256-1262
24. Demers L, Oremus M, Perrault A, Champoux N, Wolfson C. Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of functional and quality of life scales. J Geriatr Psychiatry Neurol. 2000 ; 13 (4). 170-180
25. Conde-Sala JL, Garre-Olmo J, Turro-Garriga O, Lopez-Pousa S, Vilalta-Franch J. Factors related to perceived quality of life in patients with Alzheimer's disease: the patient's perception compared with that of caregivers. Int J Geriatr Psychiatry. 2009 ; 24 (6). 585-594
26. Sands LP, Ferreira P, Stewart AL, Brod M, Yaffe K. What explains differences between dementia patients' and their caregivers' ratings of patients' quality of life?. Am J Geriatr Psychiatry. 2004 ; 12 (3). 272-280